NCT05058092 - Evaluation of the Effectiveness of the Remedee Solution in Fibromyalgia | Biotech Hunter

Enrollment

170

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

July 15, 2022

Study Completion Date

February 28, 2023

Conditions

Fibromyalgia

Interventions

DEVICE

Immediate Remedee Solution

"* D0 to M3: Remedee Solution + medical care~* M3 to M6: Remedee Solution without personalized support + medical care~* M6 to M9: medical care only"

DEVICE

Delayed Remedee Solution

"* D0 to M3: medical care only~* M3 to M6: Remedee Solution + medical care~* M6 to M9: Remedee Solution without personalized support + medical care"

Trial Locations (8)

University Hospital of Grenoble Alps, Grenoble

CHU de Montpellier, Montpellier

Cabinet libéral Dr. Lorenzi-Pernot, Mornant

Hôpital Lariboisière - Assistance Publique Hôpitaux de Paris, Paris

CHU de Rouen, Rouen

Hôpital Foch, Suresnes

Centre Hospitalier de Valenciennes, Valenciennes

Médipôle hôpital mutualiste, Villeurbanne

All Listed Sponsors

lead

Remedee SA

INDUSTRY